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Summary: The effect of Psidium guajava extract on erythromycin-induced liver damage in albino rats was 
investigated using 30 normal rats grouped into six . Group I and II served as the normal and treatment controls that 
were administered with normal saline and 100mg/kg body weight of erythromycin stearate daily for 14 days 
respectively. Rats in group III were administered 450mg/kg body weight of Psidium guajava only for 7 days while 
rats in groups IV, V and VI were administered Psidium guajava extract for 7 days and 100mg/kg body weight of 
erythromycin for 14 days. Histopathological investigation of the liver tissues revealed striking oedema and mild 
periportal mononuclear cell infiltration of hepatic cords in the liver of rats administered 100 mg/kg of erythromycin 
stearate and 300/450 mg/kg
 
of Psidium guajava extract. Pretreatment with 150 mg/kg of Psidium guajava extract 
showed a slight degree of protection against the induced hepatic injury caused by 100 mg/kg of erythromycin 
stearate. Biochemical analysis of the serum obtained revealed a significant increase in serum levels of hepatic 
enzymes measured in the groups administered with 100 mg/kg of erythromycin stearate and 300/450 mg/kg of 
Psidium guajava extract compared to the control groups and those pretreated with 150 mg/kg of Psidium guajava 
extract. This study has shown that the aqueous extract of psidium guajava leaf possesses hepatoprotective property 
at lower dose and a hepatotoxic property at higher dose but further studies with prolonged duration is recommended. 
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Introduction 
Erythromycin stearate is a macrolide antibiotic 
which has an anti microbial spectrum slightly wider 
than that of penicillin and is effective against many 
gram-positive and gram negative bacteria. It prevents 
bacterial growth by interfering with their protein 
synthesis. Erythromycin is actively transported to the 
site of infection, where during active phagocytosis, 
large concentration of erythromycin are released and 
is used in the treatment of pneumonia, tonsillitis, 
bronchitis, gonorrhea, pelvic inflammatory disease 
and urinary tract infections. Its main elimination 
route is the bile and a small portion in the urine and 
side effects associated with the drug include diarrhea, 
nausea, abdominal pain, vomiting and massive liver 
failure. 
The plant Psidium guajava is from the family-
myrtaceae, it is a small tree about 8m high and often 
cultivated throughout the tropics with the leaves and 
the fruit been the most used part of the plant is. The 
long history of guava for medicinal purposes led to 
the documentation of its properties/actions which 
includes antioxidant effect which is beneficial to the 
heart as a cardiprotective agent (Jimenej-Escrig 
2002), its analgesic, anti-bacterial, anti-dysenteric, 
anti-malarial and anti-ulcerous properties has also 
been documented. Guava has also been used as a 
cardio depressant, CNS depressant, cough 
suppressant, hypotensive agent, sedative and a 
vasoconstrictor. Other properties/action documented 
by traditional users include: anti-anxiety, anti-
convulsant, blood cleanser and a menstrual stimulant. 
The fruit is still enjoyed as a sweet treat and for 
medicinal uses by indigenous peoples throughout the 
rain forest up till today (Gill, 1992).chemical analysis 
of guava plant extract have revealed the presence of 
anti-microbial compounds (Arima, 2002), tannins, 
phenol triterpenes, flavonoids, guajivolic acid, 
guajavanoic acid, linolenic acid, linoleic acid, 
guavacoumaric acid, galaturonic acid, asphaltic acid, 
benzaldehyde, essential oils, saponins, carofenoid, 
cectin, fibre ,fatty acids and a high content of 
vitamins C and A in its fruit (Suntornonk et al 2002). 
The leaves are rich in flavonoids, (quercetin) 
attributing for most of its therapeutic activity. 
The common names of this plant include guaba in 
Yoruba, giba in Hausa, gova in Igbo and ugwaba in 
Efik (Gbile, 1984, Okujagu et al 2005). This study 
was therefore designed to determine the hepato- 
protective effect of psidium guajava on erythromycin 
induced liver damage in albino rat.  
 
Materials and methods 
Collection and identification of plant materials 
The fresh leaves of Psidium guajava where 
obtained within the University of Maiduguri campus 
which was identified and authenticated by Dr. S.S. 
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Sanusi (Plant Taxonomist) of the Department of 
Biological Sciences, University of Maiduguri, Borno 
state. A total of 500g of the fresh leaves were 
harvested and dried at room temperature which was 
then pulverized into powder using a pestle and 
mortar.  
 
Preparation of extract 
A total of two hundred and fifty grams of the 
powdered leaves were boiled in distilled water at 
100
0 
C resulting in a mean yield of 100.8±2g. The 
extract obtained was concentrated in a water bath 
until a constant dark sticky residue was obtained, this 
was further oven dried and maintained in a dessicator 
until a constant weight was obtained. The dried 
extract obtained was stored in a tightly stoppered 
container in a refrigerator at -4°C until required. 
Stock solution of the extract was prepared by 
dissolving 5g weight of the powdered extract in 50 
mL of normal saline and the concentration used was 




Animals and Husbandry. 
This study was carried out in the Departments of 
Human Anatomy and Physiology, University of 
Maiduguri between June and October, 2007. A total 
of 30 male Wister albino rat weighing 100g and 210g 
and 3-4 months old were used for the study. The rats 
were purchased from the animal house of the 
Department of Pharmacology and Pharmaceutical 
Sciences, University of Jos, Plateau State, Nigeria. 
Following an acclimatization period of 2 weeks, the 
rats were individually identified by color tattoo and 
weighed. The rats were kept in plastic cages under 
standard laboratory conditions at room temperature 
with 12hrs light/dark cycle with access to standard 
laboratory diet (Sanders Nigeria Limited, Kaduna) 
and drinking water ad libitum. 
 
Experimental protocol. 
A total of thirty male Wister albino rats were used 
in this study, they were weighed and randomly 
divided into six groups of 5 rats each (I-VI). Group I 
served as the normal control and were administered 
normal saline equivalent to the volume administered 
to the highest dosed experimental rats.Rats in group 
II served as the treatment control and were 
administered 100mg/kg body weight of erythromycin 
stearate, for 14 days via oral intubation in order to 
induce liver damage (Hameid, 2007). Group III was 
administered psidium guajava extract (450mg/kg 
body weight) once a day for seven days according to 
the method of (Hewawasam et al, 2004) via oral 
intubation. Group IV was administered erythromycin 
starate 100mg/kg body weight and psidium guajava 
150mg/kg body weight for 14 days and 7 days 
respectively via oral intubation.   Group V received 
psidium guajava 300mg/kg body weight and 
erythromycin starate 100mg/kg for same duration 
while rats in Group VI receive 450mg/kg body 
weight of psidium guajava and erythromycin starate 
100mg/kg for the same duration. All the 
administration (erythromycin stearate and pdisium 
guajava) were done daily for the whole period (21 
days) and then sacrificed. 
 
Biochemical analysis 
Blood collected from the animals through 
transection of the jugular vein were put into sterile 
bottles and centrifuged at a rate of 12,000 revolutions 
per minute (rpm) for 10 min. The clear serum 
obtained were analyzed for Aspartate transaminase 
(AST), Albumin, Alanine transaminase (ALT), 
Alkaline phosphatase (ALP) , Conjugated and Total 
Bilirubin using Randox Laboratory kits at the 
Department of Chemical Pathology, University of 
Maiduguri Teaching Hospital Maiduguri. 
 
Histological analysis 
 The liver tissue obtained was carefully dissected 
out, weighed, fixed in Bouins fluid, embedded in 
paraffin and sectioned at 5 µm. Sections were stained 
with Haematoxylin and Eosin and mounted in 
Canada balsam. Light microscopic examination of 
the sections was then carried out. 
 
Statistical analysis 
 Numerical data obtained from the study were 
expressed as the mean value ±standard error of mean. 
Differences among means of control and treated 
groups were determined using statistical package 
(GraphPad Instat). A probability level of less than 5% 
(p<0.05) was considered significant.  
 
Results  
Gross Anatomical Observation 
The liver of the control group showed normal 
gross features while those of the treatment group 
administered with erythromycin stearate presented 
with livers that were enlarged (data not shown).     
                                                                                                
The effect of the administration of Erythromycin 
stearate and extract on mean body weight 
There was a significant loss in the body weights 
of the rats administered with erythromycin stearate 
and a slight loss in body weights of rats administered 
with both the extract and erythromycin stearate 
compared to the control group that had a steady 
weight gain (Table 1.) 
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The effect of the administration of the extract and 
erythromycin on biochemical parameters :  
Administration of 100 mgkg
-1
erythromycin 
stearate was observed to have caused increases in all 
parameters with only the serum levels of conjugated 
and total bilirubin displaying significance (p<0.05) 
while albumin level was significantly (p<0.01) 
decreased. Administration of 450 mgkg
-1 
of psidium 
guajava extract alone caused a significant decrease 
(p<0.05) in the serum levels of ALAT and total 
protein. Pretreatment with 100 mgkg
-1
of psidium 
guajava extract against 100 mgkg
-1
 of erythromycin 
stearate was able to reverse the hepatoxic effect of 
the stearate though not to a significant level while 
pretreatment with 300 and 450 mgkg
-1
  of the extract 
only potentiated the hepatotoxic effect of 
erythromycin stearate by the significant 
increase(p<0.05-0.01)  noticed in all the serum 
parameters analysed (Table 2). 
 
Histological Findings 
Liver tissues obtained from the control group 
presented with normal liver architecture (Fig.1). Rats 
administered with 450mgkg
-1
 of psidium guajava 
extract presented with mild oedema compared to the 
normal control group (Fig .2). Rats treated with 
100mgkg
-1
 body weight of erythromycin stearate 
presented with distortion of the normal 
histoarchitecture of the liver which was evident by 
striking oedema and mild periportal mononuclear 
infiltration (Fig.3). In the group treated with psidium 
guajava (150 mg/kg body weight) and erythromycin 
stearate (100mg/kg body weight) there was aggregate 
of lymphocytes and periportal infiltration of 
inflammatory cells especially around the portal triad 
with a slight degree of hepatoprotection (Fig 4). In 
the group treated with psidium guajava (300 and 
450mg mg/kg) body weight) and erythromycin 
stearate (100mg/kg body weight) moderate edema 
and fibrosis were the histopathological features 
observed (Fig 5). 
 
Table 1: Effect of the administration of erythromycin and extract on mean body weights 
 
















I 0 0 168.75±8.84 180.80±3.25 12.05 6.66 
II 0 100 208.93±7.65 202.08±11.18 6.85 3.38 
III 450 0 176.15±4.03 205.05±6.44* 28.90 14.09 
IV 150 100 149.98±21.00 193.03±25.72* 43.05 22.30 
V 300 100 130.15±11.95 158.05±15.63 27.90 17.65 
VI 450 100 209.03±16.78 223.00±28.17 13.97 6.26 
 
Table 2 :  Effect of the administration of erythromycin stearate and extract on biochemical parameters 
 














 extract erythromycin 












3.5 ± 0.50 






78.25 ±  
1.75 
32.5 ±   
o.65∗∗ 
8.0 ±  
0.41∗ 
5.25 ±  
0.48∗ 
III 450 0 99.5 ±   
1..50 
39 ±  
2.04∗ 
108 ±  
9.42 
63.75 ±  
5.63∗ 
30.25 ±  
2.25 
8.25 ±  
0.63 
5. ±  0.41 
IV 150 100 121.5±    
7.86 
56 ±  
2.04∗ 
108 ±  
2.04 
63.75 ±  
5.63∗ 
.30.25 ±  
2.25 
8.25 ±  
0.63 
5. ±  041 
V 300 100 194.5 ±   
0.50∗∗ 
79 ±   
7.00∗∗ 
162 ±  
1.55∗∗ 
84.5 ±   
1.50 
31.5 ±  
0.50 
9.5 ±  
0.50 
7.5 ±   0.50∗ 
VI 450 100 132± 2.00 61±  
1.00∗∗ 




35.5 ±  
0.50∗ 
8.5 ±  
0.50 
4.5 ±  0.50 
           Significance relative to control (Group I) *=P< 0.05, * *= P<0.01, ** *= P<0.001,  Significance relative to group IV (300 
mgkg-1) a = p< 0.05, N = 5 Results are presented as Means ± SEM.  ASAT = Aspartate Aminotransaminases, ALAT = Alanine 
Aminotransaminases , ALP = Alkaline Phosphatase,  ALB = Albumin, TP = Total protein  and CB=Conjugated Bilirubin 





Fig. 1: Micrograph of the liver of a control rat showing 
normal liver parenchyma with Central vein (V) and 
Sinusoids (S) H and E stain. Mag. x 100 
 
 
Fig 2: Micrograph of the liver of a rat administered 100 
mgkg-1 of erythromycin  showing stricking edema (O) and 
periportal mononuclear infiltration(M) and sinusoid(S) H 
and E stain. Mag. x 200 
 
 
Fig 3:  Micrograph of the liver of a rat administered 450 
mgkg-1 of the aqueous extract of psidium guajava  showing  
mild edema (O) , hepatic cord (H) and portal triad (P) H 
and E stain. Mag. x 400 
 
Discussions 
The study was designed to study the effect of 
psidium guajava extract on erythromycin induced 
liver damage in rats.  The loss of body weight 
observed in the groups administered erythromycin 
together with psidium guajava extract when 
compared with the rats in the control group that were 
administered only normal saline might be attributed 
to the loss of appetite observed during the course of 
the study which might have led to decrease in food 
intake or lesions in the intestine leading to 
malabsorption (Rabo, 1998).  
It has been shown that erythromycin stearate 
caused increase in the levels of plasma enzymes 
(aspartate aminotransferase and alanine 
aminotransferase), total bilirubin and hepatomegaly 
in the liver (Hameid, 2007) ALAT and ASAT are 
liver enzyme whose levels increase due to release of 
enzymes from damaged hepatocytes.  
The results of this study showed that the 
administration of erythromycin to rats caused an 
increase in the levels of ALAT, ASAT, Alkaline 
Phosphatase and Bilirubin , but the increase was only 
significant for ALAT. Alkaline phosphatase levels 
increase remarkably in diseases “that impair bile 
formation and to a lesser extent in hapatocellular 
diseases. 
For the groups administered 150kg/kg, 
300mg/kg and 450mg/kg of extract and erythromycin 
(100mg/kg), there was significant increase in the 
levels of ALAT, ASAT, ALP and total protein 
(P<0.05). This elevation was seen to be more at a 
dose of 300mg/kg and 450mg/kg thus indicating 
hepatotoxicity of the liver.  ALAT is liver specific 
and thus any increase in its level is a clear indicator 
of injury to the hepatocytes of the liver. (Ellis et al 
1978).  At low dose, there were insignificant 
increases in the level of this parameter indicating a 
decreased hepatotoxicity of the liver i.e. an anti 
hepatotoxic affect of the extract this effect may be 
due to the presence of flavonoids in the extract which 
are said to be hepatoprotective (Trease and Evans 
1989), this findings agrees with earlier works of Sai 
et al (1998) using the green tea (Camelia simensis) 
which attributed the hepatoprotection observed in 
their study to the presence of polyphenols considered 
to be bioflavonoids which in turn is a sub category of 
the larger group of polyphemol (Tey et al 1988). A 
possible mechanism of action of psidiumm guajava 
as hepatoprotective agent could be through its 
antioxidant activity. Oedema in this result denotes 
excess plasma fluid in the interstitium which 
normally causes an expansion in the intracellular 
matrix and a major local manifestation of acute 
inflammation in dividing resident of lymphocytes or 
macrophages (Kumar,et al 2004). 
It observed in this study, that administration of 
erythromycin causes liver damage in the rats which is 
characterized by edema and periportal mononuclear 
infiltration of inflammatory cell which agrees to a 
similar work by  Hameid (2004) that established the 
role of erythromycin  stearate as a hepatotoxin. The 
experimental groups  administered the various dose 
of   the  extract and  erythromycin stearate showed   
 





Fig 4: Micrograph of the liver of a rat administered 150 
mgkg-1 of the aqueous extract of psidium guajava  and 100 
mgkg-1 of erythromycin  showing  slight hepatoprotection 
with aggregates of lymphocytes (L) , periportal 
mononuclear infiltration (M) H and E stain. Mag. x 400 
 
 
Fig 5: Micrograph of the liver of a rat administered 
300/450 mgkg
-1 
 of the aqueous extract of psidium 
guajava  and 100 mgkg
-1 
of erythromycin  showing  






aggregate of lymphocyte, infiltration of macrophages 
around the portal triad, mild edema and portal triad 
with fibrosis an indication of liver damage. The 
histomorphology of the liver administered lower 
doses of the extract (150mg/kg) showed slight 
hepatoprotection as compared to the group 
administered with medium and high dose of the 
extract (300mg/kg and 450mg/kg) thus 
complementing the result obtained from serum 
biochemical analysis. 
This study has shown that the aqueous extract of 
psidium guajava leaf possesses hepatoprotective 
property at lower dose and a hepatotoxic property at 
higher dose but further studies with prolonged 
duration is recommended. 
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